Swiss Respiratory Biotech Windward Up 7.9% in US Trading Debut
Bloomberg Markets
13 lis 2026, 17:45Crypto
1 min read
Swiss respiratory biotech Windward Bio Group AG shares rose 7.9% in their US trading debut following a $225 million fundraising through IPO and private placement.
The company raised approximately $225 million through a combination of initial public offering and private placement before its market debut.
Related
Article written by AI
Z.ai GLM-4.5-FlashFree